凝集素甘露糖結(jié)合蛋白2樣蛋白抗體
產(chǎn)品名稱(chēng)： 凝集素甘露糖結(jié)合蛋白2樣蛋白抗體
英文名稱(chēng)： LMAN2L/VIPL
產(chǎn)品編號(hào)： bs-18307R
產(chǎn)品價(jià)格： null
產(chǎn)品產(chǎn)地： 北京
品牌商標(biāo)： BIOSS
更新時(shí)間： 2025-08-18T10:57:58
使用范圍： WB=1:100-500,ELISA=1:500-1000,IHC-P=1:100-500,IHC-F=1:100-500,ICC=1:100-500,IF=1:100-500,
北京索萊寶科技有限公司
- 聯(lián)系人 : 索萊寶-龔思雨
- 地址 : 北京市北京經(jīng)濟(jì)技術(shù)開(kāi)發(fā)區(qū)環(huán)科中路16號(hào)26幢3層301
- 郵編 :
- 所在區(qū)域 : 北京
- 電話(huà) : 181****6239 點(diǎn)擊查看
- 傳真 : 點(diǎn)擊查看
- 郵箱 : 3193328036@qq.com
- 二維碼 : 點(diǎn)擊查看
Lectin mannose-binding 1, also designated vesicular integral-membrane protein (VIP36), and lectin mannose-binding 2, also designated ERGIC-53, comprise a family of membrane bound, ubiquitously expressed proteins involved in the selective transport of newly synthesized glycoproteins from the endoplasmic reticulum to the ER-Golgi intermediate compartment. VIPL (VIP36-like protein), also known as LMAN2L (lectin, mannose-binding 2-like), is a 348 amino acid single-pass type I membrane protein that localizes to the endoplasmic reticulum and Golgi apparatus. Containing one L-type lectin-like domain, VIPL is highly expressed in skeletal muscle and kidney, and is found at intermediate levels in heart, liver and placenta, and low levels in brain, thymus, spleen, small intestine and lung. VIPL is suggested to be involved in the regulation of export from the endoplasmic reticulum of a subset of glycoproteins. VIPL may function as a regulator of ERGIC-53. VIPL exists a two alternatively spliced isoforms.